Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.66 USD | +3.27% | +5.90% | +40.13% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.13% | 2.87B | |
+15.74% | 121B | |
+13.50% | 107B | |
-5.38% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.57% | 15.31B | |
+3.32% | 14.08B | |
+24.88% | 11.74B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Insider Sell: Ptc Therapeutics